High-Purity (R,R)-(-)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine for Advanced Chemical Synthesis

Discover the capabilities of a premium chiral ligand essential for cutting-edge asymmetric catalysis. As a leading manufacturer in China, we provide high-purity (R,R)-(-)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine to drive innovation in your chemical processes. Request a quote today!

Get a Quote & Sample

Key Advantages of Our Chiral Ligands

Superior Catalytic Performance

Leverage the unique structure of our (R,R)-(-)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine to optimize reaction kinetics and selectivity in your asymmetric synthesis projects. Buy now to elevate your research.

Uncompromising Quality Assurance

We guarantee a minimum purity of 98% for our chiral ligands, ensuring that every batch meets rigorous standards for demanding chemical applications. Purchase with confidence from our reliable supply chain.

Cost-Effective Sourcing

As a direct manufacturer, we offer competitive pricing for our (R,R)-Jacobsen's Ligand, making advanced catalytic solutions accessible for your budget. Request a quote for bulk orders.

Broad Application Spectrum

Asymmetric Catalysis

A cornerstone ligand for a multitude of enantioselective transformations, enabling the synthesis of chiral molecules crucial for pharmaceuticals and agrochemicals. Buy high-purity ligand today.

Material Science Innovation

Investigate its utility in the design of novel polymers and functional materials, where its coordination chemistry can impart unique properties. Contact us for supplier details.

Pharmaceutical Intermediate Development

Crucial for creating enantiomerically pure compounds, this ligand is invaluable in drug discovery and development. Source your chiral requirements from our expert manufacturers.

Research and Development

An essential reagent for academic and industrial researchers exploring new catalytic pathways and chemical syntheses. Purchase this versatile compound to advance your R&D goals.